Intech Investment Management LLC boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 55.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 32,650 shares of the company's stock after purchasing an additional 11,586 shares during the quarter. Intech Investment Management LLC's holdings in HealthEquity were worth $3,133,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Wealthfront Advisers LLC purchased a new position in shares of HealthEquity in the 4th quarter worth about $10,304,089,000. Wasatch Advisors LP increased its stake in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company's stock valued at $635,065,000 after purchasing an additional 483,269 shares in the last quarter. Raymond James Financial Inc. bought a new stake in HealthEquity during the 4th quarter valued at about $45,728,000. Geneva Capital Management LLC lifted its stake in shares of HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock worth $100,642,000 after buying an additional 206,894 shares in the last quarter. Finally, Barclays PLC grew its holdings in shares of HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after buying an additional 112,667 shares during the last quarter. Institutional investors own 99.55% of the company's stock.
HealthEquity Price Performance
Shares of NASDAQ:HQY traded up $5.44 during midday trading on Monday, reaching $90.32. 1,537,550 shares of the company were exchanged, compared to its average volume of 697,306. The stock has a market cap of $7.83 billion, a PE ratio of 82.86, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The business's fifty day moving average is $104.90 and its two-hundred day moving average is $95.76. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.
Analysts Set New Price Targets
HQY has been the topic of several analyst reports. KeyCorp lowered their price objective on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Monday. Raymond James boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Tuesday, February 25th. Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. Wells Fargo & Company increased their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Finally, JMP Securities lifted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, HealthEquity has an average rating of "Moderate Buy" and an average target price of $113.69.
Check Out Our Latest Research Report on HQY
Insider Buying and Selling
In other news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.20% of the stock is owned by company insiders.
HealthEquity Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
